Literature DB >> 16818728

Endothelial growth factors VEGF and bFGF differentially enhance monocyte and neutrophil recruitment to inflammation.

Sandra I Zittermann1, Andrew C Issekutz.   

Abstract

Vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) are produced at sites of inflammation. Previously, we demonstrated that bFGF enhances leukocyte recruitment and endothelial cell adhesion molecule (CAM) expression during inflammation. Here, we investigated the influence of VEGF during acute inflammation and whether VEGF and bFGF cooperate to modulate leukocyte recruitment. Inflammation was induced in skin of rats by intradermal injection of inflammatory stimuli +/- VEGF +/- bFGF. Migration of 51Cr-monocytes and 111In-polymorphonuclear leukocytes (PMN) to the dermal lesions and 125I-anti-CAM monoclonal antibody binding to the dermal vasculature were quantitated after 2 h. VEGF significantly enhanced tumor necrosis factor alpha (TNF-alpha)-induced monocyte recruitment by 39 +/- 16% and increased P-selectin, E-selectin, and intercellular CAM-1 expression by two- to threefold over TNF-alpha alone. However, recruitment of monocytes to TNF-alpha + interferon-gamma (IFN-gamma) and of PMN to all stimuli tested was not affected by VEGF. In contrast, bFGF enhanced recruitment of both leukocyte types to all stimuli tested. With the potent TNF-alpha + IFN-gamma stimulus, in contrast to bFGF, VEGF did not enhance E-selectin or ICAM-1 expression. bFGF, but not VEGF, increased the chemotactic activity for PMN in TNF-alpha + IFN-gamma-inflamed sites by 54%. The limited effect of VEGF on these mechanisms likely contributed to the differential effect of VEGF and bFGF on leukocyte recruitment. However, VEGF + bFGF increased PMN recruitment more than did either factor alone. Thus, bFGF and VEGF differentially but synergistically enhance leukocyte recruitment to inflammatory stimuli and individually as well as jointly function as positive regulators of inflammatory cell recruitment.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16818728     DOI: 10.1189/jlb.1205718

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  31 in total

1.  Vascular endothelial growth factor-C promotes alloimmunity by amplifying antigen-presenting cell maturation and lymphangiogenesis.

Authors:  Amir R Hajrasouliha; Toshinari Funaki; Zahra Sadrai; Takaaki Hattori; Sunil K Chauhan; Reza Dana
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-03-09       Impact factor: 4.799

2.  Degradable PLGA scaffolds with basic fibroblast growth factor: experimental studies in myocardial revascularization.

Authors:  Ying Wang; Xiao-Cheng Liu; Jian Zhao; Xiang-Rong Kong; Rong-Fang Shi; Xiao-Bin Zhao; Cun-Xian Song; Tian-Jun Liu; Feng Lu
Journal:  Tex Heart Inst J       Date:  2009

Review 3.  The link between major histocompatibility complex antibodies and cell proliferation.

Authors:  Nicole M Valenzuela; Elaine F Reed
Journal:  Transplant Rev (Orlando)       Date:  2011-07-30       Impact factor: 3.943

4.  Insights into the Dual Role of Inflammation after Spinal Cord Injury.

Authors:  Ruslan Rust; Julia Kaiser
Journal:  J Neurosci       Date:  2017-05-03       Impact factor: 6.167

Review 5.  VEGF non-angiogenic functions in adult organ homeostasis: therapeutic implications.

Authors:  Jincai Luo; Yan Xiong; Xiaofan Han; Yao Lu
Journal:  J Mol Med (Berl)       Date:  2011-03-02       Impact factor: 4.599

Review 6.  Role of the endothelium in inflammatory bowel diseases.

Authors:  Walter E Cromer; J Michael Mathis; Daniel N Granger; Ganta V Chaitanya; J Steven Alexander
Journal:  World J Gastroenterol       Date:  2011-02-07       Impact factor: 5.742

7.  Identification and characterization of VEGF-A-responsive neutrophils expressing CD49d, VEGFR1, and CXCR4 in mice and humans.

Authors:  Sara Massena; Gustaf Christoffersson; Evelina Vågesjö; Cédric Seignez; Karin Gustafsson; François Binet; Carmen Herrera Hidalgo; Antoine Giraud; Jalal Lomei; Simone Weström; Masabumi Shibuya; Lena Claesson-Welsh; Pär Gerwins; Michael Welsh; Johan Kreuger; Mia Phillipson
Journal:  Blood       Date:  2015-08-18       Impact factor: 22.113

8.  Expression patterns of angiopoietin-1, -2, and tie-2 receptor in ulcerative colitis support involvement of the angiopoietin/tie pathway in the progression of ulcerative colitis.

Authors:  Ayumi Yoshizaki; Toshiyuki Nakayama; Shinji Naito; Ichiro Sekine
Journal:  Dig Dis Sci       Date:  2008-12-03       Impact factor: 3.199

9.  Genetic Basis of Irritant Susceptibility in Health Care Workers.

Authors:  Berran Yucesoy; Yerkebulan Talzhanov; M Michael Barmada; Victor J Johnson; Michael L Kashon; Elma Baron; Nevin W Wilson; Bonnie Frye; Wei Wang; Kara Fluharty; Rola Gharib; Jean Meade; Dori Germolec; Michael I Luster; Susan Nedorost
Journal:  J Occup Environ Med       Date:  2016-08       Impact factor: 2.162

10.  Immature blood vessels in rheumatoid synovium are selectively depleted in response to anti-TNF therapy.

Authors:  Elena Izquierdo; Juan D Cañete; Raquel Celis; Begoña Santiago; Alicia Usategui; Raimon Sanmartí; Manuel J Del Rey; José L Pablos
Journal:  PLoS One       Date:  2009-12-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.